What is the recommended nystatin dosing regimen for oral thrush in adults and children?

Nystatin Dosing for Oral Thrush

For mild oral thrush, nystatin suspension 4–6 mL (400,000–600,000 units) four times daily for 7–14 days is the recommended topical regimen, but oral fluconazole 100–200 mg daily for 7–14 days is superior and should be used for moderate-to-severe disease or when higher cure rates are required. 1, 2, 3

Dosing by Age Group

Infants

• Premature and low birth weight infants: 1 mL (100,000 units) four times daily 3
• Full-term infants: 2 mL (200,000 units) four times daily, using a dropper to place half the dose in each side of the mouth; avoid feeding for 5–10 minutes after administration 3

Children and Adults

• Standard dose: 4–6 mL (400,000–600,000 units) four times daily, placing half the dose in each side of the mouth 1, 2, 3
• Alternative pastille formulation: 1–2 pastilles (200,000 units each) four times daily for 7–14 days 1, 4

Administration Technique

• Swish the suspension thoroughly in the mouth for at least 2 minutes to ensure contact with all affected areas 2, 4
• Swallow the medication rather than spitting it out to treat potential esophageal involvement 2
• Retain the preparation in the mouth as long as possible before swallowing 3
• Continue treatment for at least 48 hours after symptoms disappear and cultures confirm eradication of Candida albicans 2, 3

Treatment Duration

• Standard course: 7–14 days for most cases 1, 2, 4
• Extending treatment to 4 weeks may improve efficacy, particularly with pastille formulations 5
• Complete the full course even when symptoms resolve early 4

Critical Limitations of Nystatin

Nystatin has markedly inferior efficacy compared to fluconazole, with clinical cure rates of only 32–54% versus 87–100% with fluconazole. 2, 6, 7 This substantial difference stems from nystatin's poor adherence to oral mucosa and purely topical action. 2

When NOT to Use Nystatin

• Moderate-to-severe disease: Systemic fluconazole is mandatory 1, 2
• Immunocompromised patients: Topical agents are inadequate; use fluconazole 100–200 mg daily 1, 2
• Suspected esophageal involvement: Topical nystatin cannot penetrate esophageal tissue; systemic therapy is required even without dysphagia 1, 2
• Recurrent infections: Early recurrence after nystatin indicates treatment failure; switch to fluconazole rather than repeating nystatin 2

Optimizing Nystatin Efficacy (When Systemic Therapy Is Contraindicated)

• Combination therapy: Using nystatin suspension 4–6 mL four times daily plus nystatin pastilles 1–2 tablets four times daily for 2 weeks achieves higher cure rates than suspension alone 2, 5
• Pastilles alone demonstrate higher mycological cure rates than suspension alone 5, 8
• Higher pastille dose: 400,000 IU pastilles produce significantly better mycological cure than 200,000 IU 5
• Pastilles maintain antifungal activity in the oral cavity for at least 5 hours, whereas suspension activity is eliminated rapidly 8

Special Populations

Denture-Related Candidiasis

• Denture disinfection is mandatory alongside any antifungal therapy; nystatin alone will fail without proper denture hygiene 1, 4
• Remove dentures overnight during treatment 1

HIV-Infected Patients

• Use the same nystatin dosing as immunocompetent patients if topical therapy is chosen 2
• However, antiretroviral therapy is more important than antifungal choice for reducing recurrence rates 1, 4
• Patients with CD4 counts <200 cells/µL should receive systemic fluconazole rather than topical nystatin 2

Pregnancy

• Nystatin is preferred over fluconazole due to teratogenic risk with systemic azoles 2
• Use standard adult dosing: 4–6 mL four times daily for 7–14 days 1, 3

Common Pitfalls to Avoid

• Do not repeat nystatin after early treatment failure; this perpetuates inadequate therapy—switch to fluconazole instead 2
• Do not use nystatin for respiratory or gastrointestinal Candida colonization; these do not represent invasive disease and should not be treated 4
• Poor taste and gastrointestinal upset are the most common adverse effects; warn patients in advance 5
• Failure to assess for esophageal extension leads to persistent infection when only topical therapy is used 2

When to Escalate from Nystatin

• No clinical improvement within 48–72 hours warrants switching to fluconazole 100–200 mg daily 2
• Recurrence within 1 week indicates inadequate treatment; use systemic fluconazole for subsequent episodes 2
• Moderate-to-severe disease at presentation should bypass nystatin entirely and start with fluconazole 1, 2